Table 1.
Correlation between the RI of the acute phase for PvCelTOS(I133-G147), PvTRAP(P344-G374), and PvCyRPA(T289-G307), with the number of previous malarial episodes, malaria exposure time (years), and parasitemia. All samples were tested in duplicate. Statistical differences were calculated using Spearman’s correlation for non-parametric data and Pearson’s correlation for parametric data.
| Peptides versus Number of Previous Malarial Episodes | IgG | IgM |
|---|---|---|
| PvTRAP(P344-G374) | r = −0.05759; p = 0.6943 | r = −0.1642; p = 0.2595 |
| PvCelTOS(I133-G147) | r = 0.1416; p = 0.3317 | r = −0.1794; p = 0.2175 |
| PvCyRPA(T289-G307) | r = 0.06536; p = 0.6555 | r = −0.1372; p = 0.3471 |
| Peptides versus Malaria Exposure Time (years) | IgG | IgM |
| PvTRAP(P344-G374) | r = −0.07877; p = 0.5827 | r = −0.2366; p = 0.0945 |
| PvCelTOS(I133-G147) | r = 0.05917; p = 0.6800 | r = −0.3035; p = 0.0304 |
| PvCyRPA(T289-G307) | r = 0.02747; p = 0.8482 | r = −0.1063; p = 0.4624 |
| Peptides versus Parasitemia | IgG | IgM |
| PvTRAP(P344-G374) | r = 0.1972; p = 0.1451 | r = 0.2383; p = 0.0769 |
| PvCelTOS(I133-G147) | r = 0.1428; p = 0.2936 | r = 0.1873; p = 0.1669 |
| PvCyRPA(T289-G307) | r = 0.08225; p = 0.5467 | r = 0.06860; p = 0.6154 |